Filing Details

Accession Number:
0000899243-16-028604
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-07 16:05:46
Reporting Period:
2016-09-06
Filing Date:
2016-09-07
Accepted Time:
2016-09-07 16:05:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1650664 Editas Medicine Inc. EDIT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192603 P Kevin Starr C/O Third Rock Ventures, Llc
29 Newbury Street, 3Rd Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-09-06 5,890 $15.90 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,906,176 Indirect See Footnote
Footnotes
  1. Such shares were received as a distribution from Third Rock Ventures III, L.P. ("TRV III") on August 16, 2016 in a transaction exempt pursuant to Rule 16a-13 and Rule 16a-9.
  2. These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are the Reporting Person, Mark Levin ("Levin") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, the Reporting Person, Levin and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.